Pain Control In First Trimester Medical Abortion: A Randomized Trial
NCT01457521 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 250
Last updated 2016-01-13
Summary
This trial will compare two oral analgesic regimens in women undergoing first trimester medical abortion with mifepristone and misoprostol. The primary study outcome is pain.
Conditions
Interventions
- DRUG
-
Ibuprofen
Sponsors & Collaborators
- collaborator OTHER
-
Family Planning Associates Medical Group, LTD
collaborator OTHER -
Planned Parenthood of Greater New York
collaborator OTHER -
Gynuity Health Projects
lead OTHER
Principal Investigators
-
Elizabeth Raymond, MD, MPH · Gynuity Health Projects
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-10-31
- Primary Completion
- 2012-12-31
- Completion
- 2012-12-31
Countries
- United States
Study Locations
More Related Trials
-
Use of an Algorithm to Determine IV Sedation Dosing During First-trimester Surgical Abortion
NCT01994317 ·Status: COMPLETED ·Phase: NA
-
Prophylactic Analgesic and Antiemetic Regimen for Medical Abortion < 70 Days
NCT05819619 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation
NCT02314754 ·Status: COMPLETED ·Phase: PHASE4
-
Mifepristone Plus Misoprostol Versus Misoprostol Alone for 2nd Trimester Abortion (14 - 21 Weeks Last Menstrual Period (LMP))
NCT00969982 ·Status: COMPLETED ·Phase: NA
-
Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14 - 21 Weeks LMP): A Randomized-controlled Double-blinded Trial
NCT00784186 ·Status: COMPLETED ·Phase: NA
-
Medical Abortion With Mifepristone + Misoprostol (13 - 22 Weeks)
NCT01768299 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness and Safety of Combination Mifepristone/Misoprostol for Medical Abortion
NCT04905251 ·Status: TERMINATED
-
A Pilot of an Outpatient Regimen of Medical Abortion With Mifepristone and Sublingual Misoprostol in the 11 and 12 Weeks
NCT02720991 ·Status: COMPLETED ·Phase: PHASE4
-
Hydrocodone For Pain Control in First Trimester Surgical Abortion
NCT01330459 ·Status: COMPLETED ·Phase: PHASE4
-
Exploring a Patient-centered Approach to Mifepristone Administration in Medical Abortion
NCT01811056 ·Status: COMPLETED ·Phase: NA
-
Non-Pharmacologic Patient Centered Pain Control Adjuncts During First Trimester Abortion
NCT02590146 ·Status: COMPLETED ·Phase: NA
-
Mifepristone and Mid-Trimester Termination of Pregnancy
NCT00382538 ·Status: COMPLETED ·Phase: NA
-
Second Trimester Labor Induction
NCT00592215 ·Status: WITHDRAWN ·Phase: PHASE1
-
Study of Clinic-based Versus Self-use of Medical Abortion Pills
NCT03727308 ·Status: COMPLETED
-
Mifepristone Versus Laminaria Insertion for Cervical Preparation Prior to Surgical Abortion at 14-16 Weeks
NCT00986921 ·Status: COMPLETED ·Phase: NA
-
Acceptability of an Out-patient Regimen of Medical Abortion With Mifepristone and 800 Mcg Misoprostol Administered at 78-84 Days Gestation
NCT01856985 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Oral Midazolam in First-trimester Surgical Abortions
NCT01830881 ·Status: COMPLETED ·Phase: PHASE4
-
Assessing Medical Menstrual Regulation in the United States
NCT03972358 ·Status: UNKNOWN ·Phase: PHASE2
-
Same-Day Mifepristone-Misoprostol Compared to Misoprostol Only for Surgical Abortion Cervical Preparation
NCT02412618 ·Status: COMPLETED ·Phase: PHASE4
-
De-Medicalizing Mifepristone Medical Abortion
NCT00120224 ·Status: COMPLETED
-
Study of Immediate Start of Progestin Contraceptives in Medical Abortion
NCT01902485 ·Status: COMPLETED ·Phase: PHASE4
-
Ketamine Versus Fentanyl for Surgical Abortions
NCT04871425 ·Status: COMPLETED ·Phase: PHASE4
-
Comparing Two Regimens for Medical Abortion: Mifepristone + Misoprostol Versus Misoprostol Alone
NCT01387256 ·Status: COMPLETED ·Phase: PHASE4
-
Chart Review Study of Medical Abortion
NCT02841072 ·Status: COMPLETED
-
Dextromethorphan as a Novel Non-opioid Adjunctive Agent for Pain Control in Medication Abortion
NCT03480009 ·Status: COMPLETED ·Phase: PHASE3